News

Seizures of potentially dangerous weight loss drugs being sold on the black market in Scotland have soared as online dealers ...
Doctors are learning more about the wider effects of the injections, from lowering blood pressure to helping people quit ...
This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...
A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...
Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a ...
A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...
College of Charleston's Kindred Hurtado examines one woman's weight-loss journey with the assistance of semaglutides.
The ruling means that small-scale compounders must immediately stop making their versions of Novo’s Ozempic and Wegovy, while larger, federally licensed compounders have until May 22 to keep producing ...
Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...
A new weight loss drug that's being trialled as a daily pill and could rival Ozempic has delivered some astonishing results.
Elon Musk has revealed why he prefers to use Mounjaro over Ozempic. Ozempic is a medication that helps to bring down a person ...
GLP-1 receptor agonists such as semaglutide and tirzepatide have proven to be highly effective in supporting weight loss by regulating appetite and metabolism. These medications work by mimicking ...